ArticleiScience2024
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models.
Suresh Bugide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleiScience2024
Suresh Bugide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.